Trending...
- Veterans Day 2025: Honoring Service Through Storytelling
- U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
- purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
~ Q'Apel Medical (Q'Apel), a leading medical device company, has recently announced the receipt of CE mark certification for its innovative Armadillo SelectFlex™ Neurovascular Access System. This groundbreaking 7F system, equipped with patented SelectFlex™ Technology, is specifically designed to simplify neurovascular interventions.
According to Pascal Jabbour, MD, FAANS, FACS, FAHA, The Angela and Richard T. Clark Distinguished Professor of Neurological Surgery and Radiology at Thomas Jefferson University Hospital in Philadelphia, PA, navigating the complex anatomy of the neurovasculature can be extremely challenging. While flexible access catheters are necessary for maneuvering through tight twists and turns, they often lack the necessary support and stability for device delivery once in position. However, with Armadillo's one-and-done solution, physicians can easily transform the catheter from highly trackable to highly supportive as needed throughout the procedure with just a simple injection or withdrawal of 0.2cc of saline.
More on The PennZone
The Armadillo Neurovascular Access System with SelectFlex™ Technology offers physicians the versatility they need to confidently tackle a wide range of neurovascular interventions. Its low-profile 7F catheter allows for a biaxial approach regardless of access site, accelerating delicate procedures and eliminating the complexity and cost associated with conventional tri-axial configurations.
Jodie Fam, CEO of Q'Apel Medical, believes that their new system addresses the limitations of current neurovascular access catheters. She states that it provides a unique option for hospitals to standardize device usage while reducing inventory constraints and cost per procedure. Fam also expresses her gratitude towards their team for achieving this critical milestone and looks forward to expanding their international portfolio by delivering this meaningful solution to the European market and beyond in the coming months.
With its revolutionary technology and potential cost-saving benefits for hospitals, Q'Apel's Armadillo SelectFlex™ Neurovascular Access System is set to revolutionize neurovascular interventions and improve patient outcomes. The company's success in the U.S. market has paved the way for its expansion into the international market, bringing this innovative solution to more physicians and patients in need.
According to Pascal Jabbour, MD, FAANS, FACS, FAHA, The Angela and Richard T. Clark Distinguished Professor of Neurological Surgery and Radiology at Thomas Jefferson University Hospital in Philadelphia, PA, navigating the complex anatomy of the neurovasculature can be extremely challenging. While flexible access catheters are necessary for maneuvering through tight twists and turns, they often lack the necessary support and stability for device delivery once in position. However, with Armadillo's one-and-done solution, physicians can easily transform the catheter from highly trackable to highly supportive as needed throughout the procedure with just a simple injection or withdrawal of 0.2cc of saline.
More on The PennZone
- Luxury Mediterranean Estate in Gotha Sells for $1.52 Million, Closing $45,000 Over Asking
- ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
- UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
- Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
- Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
The Armadillo Neurovascular Access System with SelectFlex™ Technology offers physicians the versatility they need to confidently tackle a wide range of neurovascular interventions. Its low-profile 7F catheter allows for a biaxial approach regardless of access site, accelerating delicate procedures and eliminating the complexity and cost associated with conventional tri-axial configurations.
Jodie Fam, CEO of Q'Apel Medical, believes that their new system addresses the limitations of current neurovascular access catheters. She states that it provides a unique option for hospitals to standardize device usage while reducing inventory constraints and cost per procedure. Fam also expresses her gratitude towards their team for achieving this critical milestone and looks forward to expanding their international portfolio by delivering this meaningful solution to the European market and beyond in the coming months.
With its revolutionary technology and potential cost-saving benefits for hospitals, Q'Apel's Armadillo SelectFlex™ Neurovascular Access System is set to revolutionize neurovascular interventions and improve patient outcomes. The company's success in the U.S. market has paved the way for its expansion into the international market, bringing this innovative solution to more physicians and patients in need.
Filed Under: Business
0 Comments
Latest on The PennZone
- Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
- November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
- Valeo Health Leads a New Era of Longevity and Preventive Health in the UAE
- Torch Entertainment Presents The Frozen Zoo
- Philadelphia Based Teen Singer/Songwriter and his Producer Brother Release First Single
- Sweet Memories Vintage Tees Debuts Historic ORCA™ Beverage Nostalgic Soda Collection
- UK Financial Ltd Celebrates Global Recognition as MayaCat (MCAT) Evolves Into SMCAT — The World's First Meme Coin Under ERC-3643 Compliance
- U.S. Military to Benefit from Drone Tech Agreement with NovaSpark Energy, Plus Longer NASA Space Missions via Solar Power Leader: Ascent Solar $ASTI
- $76 Million in Gold & Silver Holdings and Expanding Production — Pioneering the Future of Gold: Asia Broadband Inc. (Stock Symbol: AABB) is Surging
- Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
- Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
- 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
- uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals
- Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
- Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch
- 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
- Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
- Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
- Diamond Wealth Advisors Experience the New York Stock Exchange and Ring the Closing Bell
- $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges